Healthtech is already transforming how we access, develop, deliver and manage care. I’m excited by companies that catalyse this revolution by gathering analysing and applying data in Life Sciences and Health.
Inga has experience investing in life science and digital health companies emerging from top UK universities. She spent some time in the US, gaining international industry and healthcare experience, as Chief of Staff in a commercial stage genetic molecular diagnostics company, and as Entrepreneur in Residence at Duke University. Her scientific training includes a DPhil and MSc in Neuroscience from the University of Oxford, and a BA from the University of Cambridge.